Pfizer share news, announcements and annual reports
NSE: PFIZERBSE: 500680Pharmaceuticals & BiotechnologySmall Cap
Pfizer Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jul 1966 on BSE, Apr 1999 on NSE
Last close ₹3,759.80up ₹25.40 (0.68%)BSE ₹3,760.40
Share price at the NSE close on 29 Oct 2026. Previous close ₹3,734.40.
29 Oct: open ₹3,749.00, high ₹3,799.00, low ₹3,732.30
52-week range of traded prices to 29 Oct 2026
₹3,589.00Low, 23 Oct 2026₹5,346.00High, 30 Oct 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹17,200 Cr327th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 23.40
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.09
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.99%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 21.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 13,53757.2% delivered
Pfizer orders, deals and press releases
40 filed, newest first.
Aug 2025
Feb 2023
May 2021
Nov 2020
2 Nov · Business
Jul 2020
Jun 2020
15 Jun · Business
Jul 2019
May 2019
28 May · Business
Jan 2019
24 Jan · Business
Dec 2018
Nov 2018
14 Nov · Business
Aug 2018
2 Aug · Business
May 2018
7 May · Business
Mar 2018
1 Mar · Business
Jan 2018
24 Jan · Business
Nov 2017
10 Nov · Business
Oct 2017
Jul 2017
May 2017
Jan 2017
Nov 2016
Aug 2016
May 2016
Apr 2016
Feb 2016
Nov 2015
Sep 2015
May 2015
Feb 2015
Jan 2015
Dec 2014
Nov 2014
Jul 2014
May 2014
Nov 2013
Apr 2012
Mar 2010
15 Mar · Business
Pfizer Ltd. has informed the Exchange that the Bombay High Court vide its Order dated February 26, 2010, has sanctioned the Scheme of Amalgamation of Duchem Laboratories Ltd., the unlisted wholly-owned subsidiary with Pfizer Ltd. A copy of the said Order is being filed with Registrar of Companies, Maharashtra, Mumbai. Further the Company noted that, the appointed date of the said Scheme of Amalgamation is December 01, 2008.
Apr 2009
13 Apr · Business
Pfizer Ltd. has informed the Exchange regarding press release dated April 13, 2009, titled "Pfizer To Make a Tender offer To Increase Stake in Pfizer Limited; This release is neither an offer to purchase nor a solicitation of an offer to sell shares of Pfizer Limited". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.